Shai Ufaz, PhD., is the CEO and co-founder of ViAqua Therapeutics, a company developing an oral delivery platform for treating aquaculture diseases. ViAqua Therapeutics was established in 2014 to address the growing need for effective, affordable solution to combat diseases in shrimp and other aquaculture species.
Shai has over 12 years of experience as a molecular biologist in biotechnology, genetic engineering, and protein expression. Previously, Shai worked as a team leader in TransAlgae, and project manager at Protalix Biotherapeutics – both Israeli biotechnology companies. Shai earned his PhD. from Tel Aviv University in the field of plant genetics and biotechnology.